Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 12:18 pm Purchase | 2025-09-30 | 13G | Warrior Met Coal, Inc. HCC | T. Rowe Price Investment Management, Inc. | 2,673,872 5.100% | 2,673,872 (New Position) | Filing History |
| 2025-11-14 12:18 pm Purchase | 2025-09-30 | 13G | Wyndham Hotels & Resorts, Inc. WH | T. Rowe Price Investment Management, Inc. | 4,606,963 6.000% | 4,606,963 (New Position) | Filing History |
| 2025-11-14 12:18 pm Purchase | 2025-09-30 | 13G | Elanco Animal Health Incorporated ELAN | T. Rowe Price Investment Management, Inc. | 31,547,970 6.400% | 31,547,970 (New Position) | Filing History |
| 2025-11-14 12:18 pm Sale | 2025-09-30 | 13G | PennyMac Financial Services, Inc. PFSI | T. Rowe Price Investment Management, Inc. | 3,748,813 7.200% | -731,380 (-16.32%) | Filing History |
| 2025-11-14 12:18 pm Purchase | 2025-09-30 | 13G | Applied Therapeutics, Inc. APLT | T. Rowe Price Investment Management, Inc. | 21,403,300 14.900% | 2,719,310 (+14.55%) | Filing History |
| 2025-11-14 12:18 pm Sale | 2025-09-30 | 13G | Avantor, Inc. AVTR | T. Rowe Price Investment Management, Inc. | 32,928,415 4.800% | -23,572,300 (-41.72%) | Filing History |
| 2025-11-14 12:18 pm Purchase | 2025-09-30 | 13G | Jasper Therapeutics, Inc. JSPR | T. Rowe Price Investment Management, Inc. | 2,057,612 7.100% | 2,057,612 (New Position) | Filing History |
| 2025-11-14 12:18 pm Sale | 2025-09-30 | 13G | NETSTREIT Corp. NTST | T. Rowe Price Investment Management, Inc. | 4,001,414 4.200% | -1,234,577 (-23.58%) | Filing History |
| 2025-11-14 12:18 pm Purchase | 2025-09-30 | 13G | Hagerty, Inc. HGTY | T. Rowe Price Investment Management, Inc. | 5,225,442 5.700% | 5,225,442 (New Position) | Filing History |
| 2025-11-14 12:18 pm Purchase | 2025-09-30 | 13G | USCB Financial Holdings, Inc. USCB | T. Rowe Price Investment Management, Inc. | 1,250,000 6.200% | 1,250,000 (New Position) | Filing History |
| 2025-11-14 12:18 pm Purchase | 2025-09-30 | 13G | Netskope, Inc. Class A Common Stock NTSK | T. Rowe Price Investment Management, Inc. | 3,100,262 6.500% | 3,100,262 (New Position) | Filing History |
| 2025-11-14 12:18 pm Sale | 2025-09-30 | 13G | Concentra Group Holdings Parent, Inc. CON | T. Rowe Price Investment Management, Inc. | 6,267,949 4.900% | -2,342,613 (-27.21%) | Filing History |
| 2025-11-14 12:18 pm Purchase | 2025-09-30 | 13G | Aebi?Schmidt Holding?AG AEBI | T. Rowe Price Investment Management, Inc. | 3,960,019 5.100% | 3,960,019 (New Position) | Filing History |
| 2025-11-14 12:18 pm Purchase | 2025-09-30 | 13G | Black Rock Coffee Bar, Inc. Class A Common Stock BRCB | T. Rowe Price Investment Management, Inc. | 1,350,111 8.800% | 1,350,111 (New Position) | Filing History |
| 2025-11-07 1:02 pm Purchase | 2025-10-31 | 13G | Karyopharm Therapeutics Inc. KPTI | T. Rowe Price Investment Management, Inc. | 2,304,242 13.800% | 1,575,476 (+216.18%) | Filing History |
| 2025-11-07 1:02 pm Purchase | 2025-10-31 | 13G | Equity Bancshares, Inc. EQBK | T. Rowe Price Investment Management, Inc. | 1,967,849 10.200% | 593,232 (+43.16%) | Filing History |
| 2025-11-07 1:02 pm Purchase | 2025-10-31 | 13G | Cabaletta Bio, Inc. CABA | T. Rowe Price Investment Management, Inc. | 10,360,326 11.300% | 1,997,837 (+23.89%) | Filing History |
| 2025-11-07 1:02 pm Purchase | 2025-10-31 | 13G | Immunome, Inc. IMNM | T. Rowe Price Investment Management, Inc. | 10,644,674 12.200% | 4,882,661 (+84.74%) | Filing History |
| 2025-11-07 1:00 pm Purchase | 2025-09-30 | 13G | Cabaletta Bio, Inc. CABA | T. Rowe Price Investment Management, Inc. | 8,362,489 9.100% | 4,688,765 (+127.63%) | Filing History |
| 2025-10-07 12:51 pm Purchase | 2025-09-30 | 13G | Avanos Medical, Inc. AVNS | T. Rowe Price Investment Management, Inc. | 4,713,494 10.200% | 955,918 (+25.44%) | Filing History |